ConductScience.org, home

Paper6338024

Interleukin 2: biology and biochemistry.

Gillis S. J Clin Immunol, 1983. Cited by 137 papers, by iCite.

Cite this record

ConductScience Library. Interleukin 2: biology and biochemistry. Papers, record 6338024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6338024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interleukin 2: biology and biochemistry.
PubMed
Journal
J Clin Immunol
PubMed
Year
1983
PubMed
Publication types
Comparative Study, Journal Article, Review
PubMed
Citations, by iCite
137
iCite
Relative citation ratio, by iCite
3.41
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gillis SS

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-2Major topic
T-LymphocytesMajor topic
Animals
Cell Division
Cytotoxicity, Immunologic
Humans
Killer Cells, Natural
Male
Mice
Protein Biosynthesis
RNA, Messenger

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15000987Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.J Immunol1971https://conductscience.org/library/papers/5000987PubMed
2236308High resolution two-dimensional electrophoresis of proteins.J Biol Chem1975https://conductscience.org/library/papers/236308PubMed
3307029T cell growth factor: parameters of production and a quantitative microassay for activity.J Immunol1978https://conductscience.org/library/papers/307029PubMed
46970230Biochemical separation of interleukin 2.J Immunol Methods1980https://conductscience.org/library/papers/6970230PubMed
56965520Two distinct factors are required for induction of T-cell growth.Nature1980https://conductscience.org/library/papers/6965520PubMed
6310861Monoclonal cytolytic T-cell lines.J Exp Med1979https://conductscience.org/library/papers/310861PubMed
76770028The functional relationship of the interleukins.J Exp Med1980https://conductscience.org/library/papers/6770028PubMed
86788848Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF.J Immunol1981https://conductscience.org/library/papers/6788848PubMed
9181845Selective in vitro growth of T lymphocytes from normal human bone marrows.Science1976https://conductscience.org/library/papers/181845PubMed
1091646Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors.J Immunol1979https://conductscience.org/library/papers/91646PubMed
11316981T-cell growth factor-mediated T-cell proliferation.Ann N Y Acad Sci1979https://conductscience.org/library/papers/316981PubMed
126168724On the heterogeneity of murine natural killer cells.J Exp Med1981https://conductscience.org/library/papers/6168724PubMed
136778951Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.J Exp Med1980https://conductscience.org/library/papers/6778951PubMed
146153171Clonal induction of helper T cells: conversion of specific signals into nonspecific signals.Int Arch Allergy Appl Immunol1980https://conductscience.org/library/papers/6153171PubMed
156445920The differentiation of cytotoxic T cells in vitro. II. Amplifying factor(s) produced in primary mixed lymphocyte cultures against K/D stimuli require the presence of Lyt 2+ cells but not Lyt 1+ cells.J Immunol1980https://conductscience.org/library/papers/6445920PubMed
166975318Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.J Immunol1981https://conductscience.org/library/papers/6975318PubMed
176968790Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.J Immunol1980https://conductscience.org/library/papers/6968790PubMed
186600178In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells.J Immunol1983https://conductscience.org/library/papers/6600178PubMed
19156241The in vitro generation and sustained culture of nude mouse cytolytic T-lymphocytes.J Exp Med1979https://conductscience.org/library/papers/156241PubMed
20308989Long-term culture of human antigen-specific cytotoxic T-cell lines.J Exp Med1978https://conductscience.org/library/papers/308989PubMed

See all 36 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 137 citations.

PMIDTitleJournalYearIn PapersSource
37457122Mechanisms and clinical implications in renal carcinoma resistance: narrative review of immune checkpoint inhibitors.Cancer Drug Resist2023https://conductscience.org/library/papers/37457122PubMed
33177289Characterization of bovine interleukin-2 stably expressed in HEK-293 cells.J Vet Med Sci2021https://conductscience.org/library/papers/33177289PubMed
32357612Neurohormonal immunoregulation.Endocr Pathol1990https://conductscience.org/library/papers/32357612PubMed
27141363IL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Oncoimmunology2016https://conductscience.org/library/papers/27141363PubMed
25992289NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade.J Immunother Cancer2015https://conductscience.org/library/papers/25992289PubMed
6609371Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6609371PubMed
6607793Functional characterization of human thymocyte subpopulations separated by density gradient centrifugation.Clin Exp Immunol1984https://conductscience.org/library/papers/6607793PubMed
6392343Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.J Clin Invest1984https://conductscience.org/library/papers/6392343PubMed
6239683Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6239683PubMed
6232206In vitro activation of natural killer-like cytotoxicity by specifically in vivo primed T-helper lymphocytes in the rat.Immunology1984https://conductscience.org/library/papers/6232206PubMed
6092906Characterization of the acquired immune deficiency syndrome at the cellular and molecular level.Mol Cell Biochem1984https://conductscience.org/library/papers/6092906PubMed
3899932Effects of cyclosporine in experimental cryptococcal meningitis.Infect Immun1985https://conductscience.org/library/papers/3899932PubMed
3872312Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome.J Clin Immunol1985https://conductscience.org/library/papers/3872312PubMed
3871418Control of human T-colony formation by interleukin-2.Immunology1985https://conductscience.org/library/papers/3871418PubMed
3735998Is lower ploidy of megakaryocytes another reason for uremic thrombocytopathy?Klin Wochenschr1986https://conductscience.org/library/papers/3735998PubMed
3486822The effects of interleukins and other soluble factors on T-lymphocyte colony formation.Immunology1986https://conductscience.org/library/papers/3486822PubMed
3486017The release of interleukin-2 (IL-2) and colony stimulating activity (CSA) in aplastic anemia patients: opposite behaviour with improvement of bone marrow function.Blut1986https://conductscience.org/library/papers/3486017PubMed
3309124Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.J Exp Med1987https://conductscience.org/library/papers/3309124PubMed
3260839Interleukin 2 inhibitor in synovial fluid.Clin Exp Immunol1988https://conductscience.org/library/papers/3260839PubMed
3114659Interleukin-2-like activity in injured rat brain.Neurochem Res1987https://conductscience.org/library/papers/3114659PubMed

See all 30 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6338024

GET https://conductscience.org/api/papers/v1/6338024/references?page=2